Research project Imaging and detection of tumor-associated glycan structures on tumor cells.
The overall objective of Glyco Imaging is to develop novel assays for detection of glycans as biomarkers associated with aggressive and metastatic cancer forms.
The assays will be developed for biomarker detection in blood, urine, cells and tissue. The training of researchers will be performed by a consortium consisting of 6 partners with biomedical, imaging and particle synthesis skills (4 groups, one institution, one technology company). This forms the basis for a very competent interdisciplinary training program with high quality in both education and research.
https://cordis.europa.eu/project/id/721297
GlycoImaging
Grant agreement ID: 721297
MSCA-ITN-2016 - Innovative Training Networks
Funded under: H2020-EU.1.3.1.
Overall budget: € 2 138 720,04
Status: Ongoing project
Start date: 1 April 2017
End date: 31 March 2021
